Published in Am J Dig Dis on October 01, 1978
Gallstones in patients with liver cirrhosis: incidence, etiology, clinical and therapeutical aspects. World J Gastroenterol (2014) 0.82
Ultrasonographic assessment of the gallbladder in 21 children with portal vein thrombosis. Pediatr Radiol (2004) 0.78
The retrieval of randomized clinical trials in liver disease from the medical literature. A comparison of MEDLARS and manual methods. Control Clin Trials (1985) 6.22
Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis. Gastroenterology (1972) 4.29
Nonassociation of adrenocorticosteroid therapy and peptic ulcer. N Engl J Med (1976) 3.19
Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology (1990) 2.99
Liver disease associated with secondary syphilis. N Engl J Med (1971) 2.51
A multicenter, randomized, double-blind trial of somatostatin in the management of acute hemorrhage from esophageal varices. Hepatology (1989) 2.40
Spontaneous bacterial peritonitis in cirrhosis: variations on a theme. Medicine (Baltimore) (1971) 2.26
Trailmaking and number-connection tests in the assessment of mental state in portal systemic encephalopathy. Am J Dig Dis (1977) 2.15
Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial. Gastroenterology (1977) 2.10
Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology (1985) 2.09
Branched-chain amino acids in the management of hepatic encephalopathy: an analysis of variants. Hepatology (1989) 2.05
Prophylactic portacaval anastomosis. Medicine (Baltimore) (1972) 1.99
Risk factors for gallbladder cancer. An international collaborative case-control study. Cancer (1995) 1.98
Photocatabolism of labeled bilirubin in the congenitally jaundiced (Gunn) rat. J Clin Invest (1971) 1.98
Antithrombotic therapy for venous thromboembolic disease. Chest (2001) 1.94
Preparation and properties of bilirubin photoisomers. Biochem J (1979) 1.82
The diagnostic approach to acute venous thromboembolism. Clinical practice guideline. American Thoracic Society. Am J Respir Crit Care Med (1999) 1.80
Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology (1998) 1.74
Isolation and properties of conjugated bilirubin from bile. Biochem J (1970) 1.70
Nitroglycerin improves the hemodynamic response to vasopressin in portal hypertension. Hepatology (1983) 1.67
Anti-Salmonella agglutinins in chronic active liver disease. Lancet (1971) 1.67
Antithrombotic therapy for venous thromboembolic disease. Chest (1998) 1.67
A rational approach to the hepatorenal syndrome. Gastroenterology (1973) 1.63
Bilitec to quantitate duodenogastric reflux: is it valid? Gastroenterology (1995) 1.62
Observer error and sampling variability tested in evaluation of hepatitis and cirrhosis by liver biopsy. Am J Dig Dis (1971) 1.61
Wedged and free hepatic venous pressure measured with a balloon catheter. Gastroenterology (1979) 1.52
Pigment gallstones. Gastroenterology (1977) 1.51
Therapeutic portacaval anastomosis: to shunt or not to shunt. Gastroenterology (1974) 1.50
Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial. Am J Dig Dis (1978) 1.47
Albumin binding of unconjugated [3H]bilirubin and its uptake by rat liver basolateral plasma membrane vesicles. Biochem J (1996) 1.46
Distal splenorenal vs. portal-systemic shunts after hemorrhage from varices: a randomized controlled trial. Hepatology (1988) 1.45
Pigment vs cholesterol cholelithiasis: comparison of stone and bile composition. Am J Dig Dis (1974) 1.44
Ammonia tolerance in the diagnosis of esophageal varices. A comparison of endoscopic, radiologic, and biochemical techniques. J Lab Clin Med (1967) 1.43
Transjugular intrahepatic portosystemic shunts versus sclerotherapy: a discussion of discordant results. Ann Intern Med (1997) 1.40
Gastric bezoar complicating gastric stapling. Am J Gastroenterol (1990) 1.40
Chronic active liver disease. The range of histologic lesions, their response to treatment, and evolution. Hum Pathol (1972) 1.40
Sensitivity and reproducibility of chemical tests for fecal occult blood with an emphasis on false-positive reactions. Am J Dig Dis (1973) 1.38
Evidence for x-linked dominant inheritance of ornithine transcarbamylase deficiency. N Engl J Med (1973) 1.37
Lactulose in the treatment of chronic portal-systemic encephalopathy. A double-blind clinical trial. N Engl J Med (1969) 1.35
Esophageal tamponade in the treatment of bleeding varices. A decadel progress report. Dig Dis Sci (1980) 1.34
A peek at the Child-Turcotte classification. Hepatology (1982) 1.34
Hyperglucagonemia in Laennec's cirrhosis. The role of portal-systemic shunting. N Engl J Med (1974) 1.29
Intraarterial vasopressin in the treatment of upper gastrointestinal hemorrhage: a prospective, controlled clinical trial. Gastroenterology (1975) 1.28
Identification of patients with cholesterol or pigment gallstones by discriminant analysis of radiographic features. N Engl J Med (1981) 1.28
Spontaneous bacterial peritonitis in cirrhosis: endemic or epidemic? Med Clin North Am (1975) 1.27
The "buried bumper syndrome": a complication of percutaneous endoscopic gastrostomy. Am J Gastroenterol (1990) 1.26
Distal splenorenal shunt vs. portal-systemic shunt: current status of a controlled trial. Hepatology (1981) 1.24
Selective intraarterial vasopressin in the treatment of upper gastrointestinal hemorrhage. Gastroenterology (1972) 1.23
Increased incidence of cholelithiasis in Laënnec's cirrhosis. A postmortem evaluation of pathogenesis. Gastroenterology (1972) 1.22
New concepts in phototherapy: photoisomerization of bilirubin IX alpha and potential toxic effects of light. Pediatrics (1980) 1.22
Evidence for conversion of bilirubin to dihydroxyl derivatives in the gunn rat. Biochem Biophys Res Commun (1972) 1.22
Ideal treatment of portal hypertension in 1985. Clin Gastroenterol (1985) 1.21
Pigment vs cholesterol cholelithiasis: clinical and epidemiological aspects. Am J Dig Dis (1975) 1.21
Bacteria and cholesterol gallstones: molecular biology comes to gallstone pathogenesis. Gastroenterology (1995) 1.21
Distinguishing malignant from normal oral tissues using FTIR fiber-optic techniques. Biopolymers (2001) 1.20
Hepatolithiasis in East Asia. Retrospective study. Dig Dis Sci (1986) 1.20
Portal-systemic encephalopathy and portacaval anastomosis: a prospective, controlled investigation. Gastroenterology (1974) 1.16
Pigment gallstone disease: Summary of the National Institutes of Health--international workshop. Hepatology (1983) 1.16
Measurement of conjugated and unconjugated bilirubin in bile. II. A new thin-layer chromatographic method. J Lab Clin Med (1976) 1.15
Pretreatment biliary lipid composition in white patients with radiolucent gallstones in the National Cooperative Gallstone Study. Gastroenterology (1982) 1.14
Distal spleno-renal shunt versus endoscopic sclerotherapy in the prevention of variceal rebleeding. A meta-analysis of 4 randomized clinical trials. J Hepatol (1992) 1.14
Ionization and self-association of unconjugated bilirubin, determined by rapid solvent partition from chloroform, with further studies of bilirubin solubility. J Lipid Res (1992) 1.13
Primary cholesterol hepatolithiasis: a disease with a different pathogenesis. Hepatology (1993) 1.12
Pigment gallstone composition in patients with hemolysis or infection/stasis. Dig Dis Sci (1986) 1.11
Unconjugated bilirubin, and the hydrolysis of conjugated bilirubin, in gallbladder bile of patients with cholelithiasis. Gastroenterology (1978) 1.11
Effect of portacaval anastomosis on hypersplenism. Dig Dis Sci (1980) 1.09
Propranolol for the prevention of first esophageal variceal hemorrhage: a lifetime commitment? Hepatology (2001) 1.09
Dilatation of severe esophageal strictures by an inflatable balloon catheter. Gastroenterology (1981) 1.09
Short-term effects of propranolol on portal venous pressure. Hepatology (1986) 1.08
The syndrome of methoxyflurane-associated hepatitis. Ann Intern Med (1974) 1.08
Evaluation of radiographic lucency or opaqueness of gallstones as a means of identifying cholesterol or pigment stones. Correlation of lucency or opaqueness with calcium and mineral. Gastroenterology (1975) 1.08
Effect of jejunal amino acid perfusion and exogenous cholecystokinin on the exocrine pancreatic and biliary secretions in man. Gastroenterology (1971) 1.07
Percutaneous versus peritoneoscopic liver biopsy. Gastroenterology (1972) 1.07
Kinetic analysis of biliary lipid excretion in man and dog. J Clin Invest (1976) 1.07
Fanconi anemia deficiency stimulates HPV-associated hyperplastic growth in organotypic epithelial raft culture. Oncogene (2008) 1.06
Systemic mycosis complicating high dose corticosteroid treatment of chronic active liver disease. Am J Gastroenterol (1980) 1.05
Serum CEA and CA 19-9: potential future diagnostic or screening tests for gallbladder cancer? Int J Cancer (1990) 1.05
Marked alkaline phosphatase elevation with partial common bile duct obstruction due to calcific pancreatitis. Gastroenterology (1976) 1.04
Analysis of ascitic fluid in cirrhosis. Dig Dis Sci (1979) 1.04
The etiology of pigment gallstones. Hepatology (1984) 1.04
Endoscopic sclerotherapy: an analysis of variants. Hepatology (1983) 1.03
A controlled comparison of continuous intraarterial and intravenous infusions of vasopressin in hemorrhage from esophageal varices. Gastroenterology (1979) 1.02
Tyrosine metabolism in patients with liver disease. J Clin Invest (1967) 1.02
Endothelin mediates pulmonary vascular remodelling in a canine model of chronic embolic pulmonary hypertension. Eur Respir J (2000) 1.02
Bilateral recurrent parotid gland swelling after endoscopy. Gastroenterology (1977) 1.01
Pigment vs cholesterol cholelithiasis: bacteriology of gallbladder stone, bile, and tissue correlated with biliary lipid analysis. Am J Dig Dis (1978) 1.01